9/17/2013

Teva Pharmaceutical Industries received FDA approval for its capecitabine tablets in two strengths: 150 mg and 500 mg. The drug is used to treat colorectal and breast cancer metastasis, and it's a generic version of Xeloda from Genentech.

Full Story:
Drug Store News

Related Summaries